Risk to quality maintenance from disruptions involving reagents, liquid nitrogen and equipment
First written in FY2021. 3 of 5 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Cell processing centers and cell storage centers are essential infrastructure for the group's business. Reagents required to process umbilical cord blood and umbilical cords, as well as liquid nitrogen used to cool long-term storage tanks, are essential resources.」
The company continues to disclose the risk of interruptions to the supply of processing and storage facilities, reagents and liquid nitrogen, along with countermeasures including multiple facilities, inventory reserves and transactions with multiple gas suppliers. - FY2025RestatedAnnual report
「As a countermeasure, the company built a new cell processing center in Yokohama in March 2021. With facilities in both Tokyo and Yokohama, it can respond even if one of them experiences a disruption.」
To address the risk to quality maintenance from disruptions involving reagents, liquid nitrogen or facilities, the company continues to operate two facilities in Tokyo and Yokohama and maintain controls under AABB and ISO 9001 standards. - FY2023RestatedAnnual report
「In March 2021, the company built a new cell processing center in Yokohama. With facilities in both Tokyo and Yokohama, it can respond even if one of them experiences a disruption.」
To address the risk to quality maintenance from disruptions involving reagents, liquid nitrogen or facilities, the company continues to operate two facilities in Tokyo and Yokohama and undergo AABB and ISO 9001 inspections. - FY2022MitigatedAnnual report
「In March 2021, the company built a new cell processing center in Yokohama. With facilities in both Tokyo and Yokohama, it can respond even if one of them experiences a disruption.」
The company explains that it established a system capable of responding if one facility experiences a disruption by operating two facilities in Tokyo and Yokohama. - FY2021First statedAnnual report
「If the supply of reagents required for cell separation and processing or liquid nitrogen used to cool the long-term storage tanks, which may be considered the core of the company, is disrupted, or if necessary equipment fails to operate normally, impairing the quality of cell transportation, separation or storage, the company's business and performance may be affected.」
The company identifies the establishment of a second facility through the new Yokohama processing center and AABB and ISO 9001 inspections as countermeasures.